Eric Joseph Daniels

Insider Reports History

Location
C/O Eyegate Pharmaceuticals Inc., 271 Waverly Oaks Rd., Ste 108, Waltham, MA
Signature
/s/ Melissa Tosca, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Eric Joseph Daniels:

Stock Role Class Num Shares Value Price $ Report Date Ownership
KIORA PHARMACEUTICALS INC Chief Development Officer Common Stock 26.4K $97.1K $3.68 Apr 1, 2025 Direct
KIORA PHARMACEUTICALS INC Chief Development Officer Stock Option (right to buy) 15.5K Apr 1, 2025 Direct

Insider Reports Filed by Eric Joseph Daniels

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KPRX KIORA PHARMACEUTICALS INC Apr 1, 2025 2 $0 4 Apr 2, 2025 Chief Development Officer
KPRX KIORA PHARMACEUTICALS INC Jul 1, 2024 2 $0 4 Jul 3, 2024 Chief Development Officer
KPRX KIORA PHARMACEUTICALS INC Jun 14, 2024 1 $7.57K 4 Jun 14, 2024 Chief Development Officer
KPRX KIORA PHARMACEUTICALS INC Sep 29, 2023 2 $0 4 Oct 3, 2023 Chief Development Officer
KPRX KIORA PHARMACEUTICALS INC Mar 3, 2023 2 $0 4 Mar 7, 2023 Chief Development Officer
KPRX KIORA PHARMACEUTICALS INC Oct 21, 2022 2 $0 4 Oct 25, 2022 Chief Development Officer
KPRX KIORA PHARMACEUTICALS INC Feb 1, 2022 1 $0 4 Feb 3, 2022 Chief Development Officer
KPRX KIORA PHARMACEUTICALS INC Oct 21, 2021 1 $0 4/A Nov 22, 2021 Chief Development Officer
KPRX KIORA PHARMACEUTICALS INC Oct 21, 2021 0 $0 3 Nov 10, 2021 Chief Development Officer